MedTrace Logo

An Exploratory Study of PRX167700 in Patients With Knee Osteoarthritis

NCT01945346 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2015-08-26

No results posted yet for this study

Summary

This is an exploratory study to evaluate a new anti-inflammatory drug, PRX167700, in subjects with painful osteoarthritis of the knee.

The purpose of this study is to investigate if PRX167700 improves the pain from osteoarthritis of the knee, and to assess its safety and tolerability. The study will also investigate PRX167700 pharmacokinetics.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

PRX167700

Oral capsule

DRUG

Placebo

Oral capsule

Sponsors & Collaborators

  • Proximagen Limited

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Proximagen Limited

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01945346 on ClinicalTrials.gov